ACRV
Price
$1.19
Change
-$0.05 (-4.03%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
38.88M
49 days until earnings call
ARWR
Price
$15.30
Change
-$0.32 (-2.05%)
Updated
Jun 20, 04:59 PM (EDT)
Capitalization
2.16B
52 days until earnings call
Interact to see
Advertisement

ACRV vs ARWR

Header iconACRV vs ARWR Comparison
Open Charts ACRV vs ARWRBanner chart's image
Acrivon Therapeutics
Price$1.19
Change-$0.05 (-4.03%)
Volume$2.34K
Capitalization38.88M
Arrowhead Pharmaceuticals
Price$15.30
Change-$0.32 (-2.05%)
Volume$30.67K
Capitalization2.16B
ACRV vs ARWR Comparison Chart in %
Loading...
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRV vs. ARWR commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRV is a Hold and ARWR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (ACRV: $1.24 vs. ARWR: $15.62)
Brand notoriety: ACRV: Not notable vs. ARWR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACRV: 30% vs. ARWR: 73%
Market capitalization -- ACRV: $38.88M vs. ARWR: $2.16B
ACRV [@Biotechnology] is valued at $38.88M. ARWR’s [@Biotechnology] market capitalization is $2.16B. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRV’s FA Score shows that 1 FA rating(s) are green whileARWR’s FA Score has 1 green FA rating(s).

  • ACRV’s FA Score: 1 green, 4 red.
  • ARWR’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACRV and ARWR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRV’s TA Score shows that 3 TA indicator(s) are bullish while ARWR’s TA Score has 3 bullish TA indicator(s).

  • ACRV’s TA Score: 3 bullish, 3 bearish.
  • ARWR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ACRV is a better buy in the short-term than ARWR.

Price Growth

ACRV (@Biotechnology) experienced а -2.36% price change this week, while ARWR (@Biotechnology) price change was -6.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.53%. For the same industry, the average monthly price growth was +31.27%, and the average quarterly price growth was +16.98%.

Reported Earning Dates

ACRV is expected to report earnings on Aug 08, 2025.

ARWR is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.16B) has a higher market cap than ACRV($38.9M). ARWR YTD gains are higher at: -16.915 vs. ACRV (-79.402). ARWR has higher annual earnings (EBITDA): -68.12M vs. ACRV (-92.1M). ARWR has more cash in the bank: 1.1B vs. ACRV (150M). ACRV has less debt than ARWR: ACRV (3.51M) vs ARWR (388M). ARWR has higher revenues than ACRV: ARWR (545M) vs ACRV (0).
ACRVARWRACRV / ARWR
Capitalization38.9M2.16B2%
EBITDA-92.1M-68.12M135%
Gain YTD-79.402-16.915469%
P/E RatioN/AN/A-
Revenue0545M-
Total Cash150M1.1B14%
Total Debt3.51M388M1%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRVARWR
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
70%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 17 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ACRV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GFAI1.200.09
+8.10%
Guardforce AI Co Limited
PAR62.970.81
+1.30%
PAR Technology Corp
CBNK31.240.15
+0.48%
Capital Bancorp
AJG317.131.00
+0.32%
Arthur J Gallagher & Co
AEO9.58-0.22
-2.24%
American Eagle Outfitters

ACRV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRV has been loosely correlated with ALLR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRV jumps, then ALLR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRV
1D Price
Change %
ACRV100%
+2.48%
ALLR - ACRV
48%
Loosely correlated
+5.51%
AURA - ACRV
40%
Loosely correlated
-1.29%
MGNX - ACRV
38%
Loosely correlated
N/A
CCCC - ACRV
38%
Loosely correlated
-3.36%
ARWR - ACRV
38%
Loosely correlated
+0.77%
More

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with DNLI. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+0.77%
DNLI - ARWR
54%
Loosely correlated
-3.63%
IMNM - ARWR
53%
Loosely correlated
-1.34%
RGNX - ARWR
53%
Loosely correlated
-1.04%
YMAB - ARWR
53%
Loosely correlated
-3.54%
BEAM - ARWR
52%
Loosely correlated
+1.92%
More